Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 625 of 984 entries
View as:

Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00314795 Org: User:
Start: 04/06/06 End: 10/31/16 Due: 10/31/17

Efficacy and Safety of Namilumab (MT203) for Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02129777 Org: User:
Start: 06/30/14 End: 02/29/16 Due: 02/28/17

Study of TAK-672 in Participants With Acquired Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT04580407 Org: User:
Start: 04/09/21 End: 11/29/22 Due: 11/29/23

Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years

Phase: N/A Priority: Normal
NCT ID: NCT01511250 Org: User:
Start: 11/16/11 End: 04/15/16 Due: 04/15/17

Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01289119 Org: User:
Start: 12/31/10 End: 12/31/11 Due: 12/31/12

Bivalent Norovirus Vaccine Study

Phase: N/A Priority: Normal
NCT ID: NCT01168401 Org: User:
Start: 09/03/10 End: 01/09/13 Due: 01/09/14

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT06615921 Org: User:
Start: 10/14/24 End: 07/31/25 Due: 07/31/26

Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01467700 Org: User:
Start: 12/31/11 End: 03/31/15 Due: 03/31/16

A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06390995 Org: User:
Start: 05/20/24 End: 03/19/27 Due: 03/19/28

A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT05428345 Org: User:
Start: 09/25/23 End: 11/30/27 Due: 11/30/28

Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.

Phase: N/A Priority: Normal
NCT ID: NCT02163915 Org: User:
Start: 06/30/14 End: 11/30/14 Due: 11/30/15

A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03339219 Org: User:
Start: 12/13/17 End: 08/25/20 Due: 08/25/21

A Study Measuring Substances Potentially Indicating Bone Problems in Adults With Type 1 Gaucher Condition

Phase: N/A Priority: Normal
NCT ID: NCT05702814 Org: User:
Start: 03/27/23 End: 05/24/24 Due: 05/24/25

Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT00760968 Org: User:
Start: 08/31/07 End: 02/28/09 Due: 02/28/10

Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation

Phase: N/A Priority: Normal
NCT ID: NCT02824432 Org: User:
Start: 08/04/16 End: 08/19/17 Due: 08/19/18

The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)

Phase: N/A Priority: Normal
NCT ID: NCT00449813 Org: User:
Start: 03/31/07 End: 11/30/08 Due: 11/30/09

A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT04589039 Org: User:
Start: 03/16/20 End: 09/11/24 Due: 09/11/25

Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT03525119 Org: User:
Start: 05/16/18 End: 07/09/19 Due: 07/09/20

Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Phase: N/A Priority: Normal
NCT ID: NCT02954848 Org: User:
Start: 11/15/16 End: 02/26/18 Due: 02/26/19

Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT00229437 Org: User:
Start: 03/31/05 End: 05/31/06 Due: 05/31/07

Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00847808 Org: User:
Start: 02/28/09 End: 04/30/10 Due: 04/30/11

Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04102163 Org: User:
Start: 01/26/21 End: 05/26/21 Due: 05/26/22

A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04464460 Org: User:
Start: 09/25/20 End: 10/30/20 Due: 10/30/21

IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults

Phase: N/A Priority: Normal
NCT ID: NCT03092791 Org: User:
Start: 06/07/17 End: 10/18/18 Due: 10/18/19

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00770445 Org: User:
Start: 05/31/08 End: 07/31/10 Due: 07/31/11